The question is urgent please!!!

Managerial case study, The case describes how the Mayo Clinic, one of the most prominent hospitals in the world, engaged designers and built a research institute, the Center for Innovation (CFI), to study the processes of healthcare provision. The case documents the many incremental innovations the designers were able to implement and the way designers learned to interact with physicians and vice-versa. In 2010 there were questions about how the CFI would achieve its stated aspiration of "transformational change" in the healthcare field. Students are asked what would a major change in health care delivery look like? How should the CFI's impact be measured? Were the center's structure and processes appropriate for transformational change? Faculty have found this a great case to discuss institutional obstacles to innovation, the importance of culture in organizational change efforts, and the differences in types of innovation.

Question 11 What does BM mean in relation to blood sugar monitoring? Question 12 What is the role of urine examination in diabetic control? Question 13 Diabetes and diet: could the authors of my favourite medical text please advise whether or not it is acceptable to have controlled quantities of refined sugar, providing the total calorie intake is kept under control? Question 14 Do non-obese patients with impaired fasting glucose, i.e. a glucose level of 6.1-6.9 mmol/L, need drug treatment with biguanides if lifestyle modifications fail to normalize? Question 15 Do non-obese patients with impaired glucose tolerance (but not fulfilling the criteria for diabetes mellitus) need drug treatment with biguanides if lifestyle modifications fail to normalize their post-prandial blood glucose measurements? Question 16 It is the Muslim month of fasting currently. I would be grateful if you could advise on how to adjust the insulin regimen of a type 1 diabetic patient, for example a 21-year-old girl who is on subcutaneous Actrapid (short-acting soluble insulin) 22 units t.d.s. 19 Diabetes mellitus and other disorders of metabolism 200 Question 17 I would like to know more about the use of the glitazone group in type 2 diabetes: its action, side-effects, precautions taken on using them. Question 18 In a patient receiving oral antidiabetics, should the drug be administered just after taking the blood sample for fasting blood glucose level (and before a meal), or just prior to the sample being taken? Question 19 What oral antidiabetics are safe in pregnancy? Question 20 Is it necessary to put all type 2 diabetics on aspirin? Question 21 In the chapter on diabetes you wrote that you should avoid tablets before age of 40 years in non-insulin-dependent diabetes mellitus (NIDDM). Why is this, because in our country most doctors are prescribing this?